Bays HE - Search Results

1

Clinical lipidology: A subspecialty whose time has come.

Orringer CE, Bays HE, Brown WV. Orringer CE, et al. Among authors: bays he. J Clin Lipidol. 2015 Sep-Oct;9(5):634-9. doi: 10.1016/j.jacl.2015.06.007. Epub 2015 Jun 17. J Clin Lipidol. 2015. PMID: 26350808 No abstract available.

2

Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.

Brown WV, Bays HE, Hassman DR, McKenney J, Chitra R, Hutchinson H, Miller E; Rosuvastatin Study Group. Brown WV, et al. Among authors: bays he. Am Heart J. 2002 Dec;144(6):1036-43. doi: 10.1067/mhj.2002.129312. Am Heart J. 2002. PMID: 12486428 Clinical Trial.

3

Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome.

Bays HE, Shah A, Lin J, McCrary Sisk C, Paolini JF, Maccubbin D. Bays HE, et al. J Clin Lipidol. 2010 Nov-Dec;4(6):515-21. doi: 10.1016/j.jacl.2010.08.020. Epub 2010 Oct 28. J Clin Lipidol. 2010. PMID: 21122699 Clinical Trial.

4

Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia.

Bays HE, Jones PH, Mohiuddin SM, Kelly MT, Sun H, Setze CM, Buttler SM, Sleep DJ, Stolzenbach JC. Bays HE, et al. J Clin Lipidol. 2008 Dec;2(6):426-35. doi: 10.1016/j.jacl.2008.10.001. Epub 2008 Nov 12. J Clin Lipidol. 2008. PMID: 21291776

5

Drugs in development for management of lipoprotein disorders.

Brown WV, Bays H, Davidson M, Goldberg A. Brown WV, et al. J Clin Lipidol. 2011 Mar-Apr;5(2):66-75. doi: 10.1016/j.jacl.2011.01.004. Epub 2011 Jan 28. J Clin Lipidol. 2011. PMID: 21392719 No abstract available.

6

Using omega-3 fatty acids in the practice of clinical lipidology.

Brown WV, Bays H, Harris W, Miller M. Brown WV, et al. J Clin Lipidol. 2011 Nov-Dec;5(6):424-33. doi: 10.1016/j.jacl.2011.09.006. Epub 2011 Oct 2. J Clin Lipidol. 2011. PMID: 22108145 No abstract available.

7

Planning a clinical trial.

Brown WV, Bays HE, Maki KC, Wild RA. Brown WV, et al. Among authors: bays he. J Clin Lipidol. 2012 Nov-Dec;6(6):484-95. doi: 10.1016/j.jacl.2012.10.001. Epub 2012 Oct 5. J Clin Lipidol. 2012. PMID: 23312046 Review. No abstract available.

8

Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).

Bays HE, Braeckman RA, Ballantyne CM, Kastelein JJ, Otvos JD, Stirtan WG, Soni PN. Bays HE, et al. J Clin Lipidol. 2012 Nov-Dec;6(6):565-72. doi: 10.1016/j.jacl.2012.07.001. Epub 2012 Jul 24. J Clin Lipidol. 2012. PMID: 23312052 Clinical Trial.

9

Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.

Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-Campoy JM, Jones SR, Kumar R, La Forge R, Samuel VT. Bays HE, et al. J Clin Lipidol. 2013 Jul-Aug;7(4):304-83. doi: 10.1016/j.jacl.2013.04.001. Epub 2013 May 31. J Clin Lipidol. 2013. PMID: 23890517

10

A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.

Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, Ceska R, Roth E, Koren MJ, Ballantyne CM, Monsalvo ML, Tsirtsonis K, Kim JB, Scott R, Wasserman SM, Stein EA; DESCARTES Investigators. Blom DJ, et al. N Engl J Med. 2014 May 8;370(19):1809-19. doi: 10.1056/NEJMoa1316222. Epub 2014 Mar 29. N Engl J Med. 2014. PMID: 24678979 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page